Prednisone delayed release (prednisone) NDC 74157-010

NDC codes

FDA NDC Directory

Product NDC (as listed)74157-010Labeler and product segments. Claims need a package NDC.

Product NDC at billing width74157-0010Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
74157-010-30	74157001030	1 BOTTLE in 1 CARTON (74157-010-30) / 30 TABLET, DELAYED RELEASE in 1 BOTTLEMarketed from Dec 15, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prednisone delayed release
Generic name (nonproprietary): prednisone
Active ingredients: Prednisone — 1 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: INA Pharmaceutics Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219477
Marketing start: Dec 15, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 74157-010_463c5b39-7eb2-d396-e063-6394a90aa451SPL ID 463c5b39-7eb2-d396-e063-6394a90aa451SPL set ID 463c7cd2-c973-5c6c-e063-6394a90a09a0RxCUI 1303125, 1303132UNII VB0R961HZTUPC 0374157010305, 0374157019308
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N474157001030 followed by a unit qualifier and the quantity

Package 74157-0010-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 17, 2025.

Indications (excerpt from the label)

Prednisone delayed-release tablets are indicated in the treatment of the following diseases or conditions: Prednisone delayed-release tablets are a corticosteroid indicated as an anti-inflammatory or immunosuppressive agent for certain allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, specific infectious diseases or conditions and organ transplantation ( 1 ) for the treatment of certain endocrine conditions ( 1 ) for palliation of certain neoplastic conditions ( 1 ) 1.1 Allergic Conditions Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adults and pediat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 219477

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219477
Product	Strength	Form · route	Labeler	Product NDC
Prednisone delayed releaseprednisone	Prednisone 2 mg/1	Tablet, Delayed releaseOral	INA Pharmaceutics Inc	74157-019
Prednisone delayed releaseprednisone	Prednisone 1 mg/1	Tablet, Delayed releaseOral	Dr. Reddys Laboratories Inc.	43598-886
Prednisone delayed releaseprednisone	Prednisone 2 mg/1	Tablet, Delayed releaseOral	Dr. Reddys Laboratories Inc.	43598-887